Milestone Scientific (NYSE:MLSS – Get Rating) and Vicarious Surgical (NYSE:RBOT – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, risk, earnings, valuation, institutional ownership and dividends.
Risk & Volatility
Milestone Scientific has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500.
Profitability
This table compares Milestone Scientific and Vicarious Surgical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Milestone Scientific | -93.22% | -75.26% | -56.17% |
| Vicarious Surgical | N/A | -74.50% | -56.58% |
Insider and Institutional Ownership
Earnings & Valuation
This table compares Milestone Scientific and Vicarious Surgical’s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Milestone Scientific | $8.81 million | 8.26 | -$8.71 million | ($0.11) | -9.45 |
| Vicarious Surgical | N/A | N/A | $5.16 million | ($0.51) | -4.31 |
Vicarious Surgical has lower revenue, but higher earnings than Milestone Scientific. Milestone Scientific is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of current recommendations and price targets for Milestone Scientific and Vicarious Surgical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Milestone Scientific | 0 | 0 | 0 | 0 | N/A |
| Vicarious Surgical | 0 | 0 | 1 | 0 | 3.00 |
Vicarious Surgical has a consensus price target of $7.00, indicating a potential upside of 218.18%. Given Vicarious Surgical’s higher possible upside, analysts clearly believe Vicarious Surgical is more favorable than Milestone Scientific.
Summary
Vicarious Surgical beats Milestone Scientific on 7 of the 12 factors compared between the two stocks.
About Milestone Scientific
Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. It operates through the following segments: Dental, Medical, and Corporate. The Corporate segment refers to executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities, and public company compliance costs. Its solutions include CompuFlo Epidural, CathCheck Verification System, and Single Tooth Anesthesia System. The company was founded on August 17, 1989 and is headquartered in Roseland, NJ.
About Vicarious Surgical
Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
